Dr. Nageh A. Garas, MD

Dr. Garas practices at Mather Hospital in Port Jefferson, New York, part of Northwell Health.

Dr. Garas' NPI, 1821181249, was assigned on September 30, 2006. Dr. Garas holds New York license 237281.

Dr. Garas' primary practice is Mather Hospital, at 75 North Country Road, Port Jefferson, NY 11777 in Suffolk County. The practice phone is (631) 473-1320.

Dr. Garas' primary practice is Mather Hospital in Port Jefferson, New York, part of Northwell Health. Dr. Garas is also affiliated with North Shore University Hospital. The medical group on file is Mather Hospital. Dmand AI also links Dr. Garas to 1 more hospital, 2 medical groups, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Garas practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Garas' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Garas is licensed in New York.

CMS data shows 1,453 Medicare services from Dr. Garas across 9 procedure codes in 2024, for 610 Medicare patients. Medicare paid $130,257 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 610 Medicare patients who saw Dr. Garas in 2024. The largest group is 75 to 84, with 231 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Garas' median patient age at 70, with 54% women.

In 2024, Dr. Garas wrote 264 Medicare Part D claims for 125 patients. 85% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $327 in total drug cost. In 2023, CMS named 123 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Garas for performance year 2024, reported through an alternative payment model (APM). Dr. Garas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Garas from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $125.